Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
60 studies found for:    metabolic syndrome | Open Studies | Interventional Studies | Adult | Phase 1, 2, 3 | Industry
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
Condition: Abdominal Obesity Metabolic Syndrome
Interventions: Drug: ALS-L1023;   Drug: placebo
2 Recruiting Metformin in the Diastolic Dysfunction of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Diastolic Dysfunction;   Insulin Resistance
Interventions: Behavioral: Lifestyle Counseling;   Drug: Metformin
3 Unknown  The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome
Conditions: Metabolic Syndrome;   Obesity
Interventions: Dietary Supplement: Coleus forskohlii extract;   Other: Placebo
4 Recruiting NWT03 and Arterial Stiffness
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: NWT-03, an egg-white protein hydrolysate;   Other: Placebo
5 Not yet recruiting Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
Conditions: Metabolic Disease;   Endothelial Dysfunction
Intervention: Biological: Peripheral Intravenous (IV) infusion of LMSCs
6 Recruiting Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents
Conditions: NAFLD;   TYPE 2 DIABETES;   METABOLIC SYNDROME
Interventions: Dietary Supplement: Resveratrol;   Dietary Supplement: Placebo
7 Unknown  Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL)
Condition: Metabolic Disease
Intervention: Dietary Supplement: LaFlavon
8 Recruiting Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Conditions: Gestational Diabetes Mellitus;   Type 2 Diabetes Mellitus;   Metabolic Syndrome;   Impaired Glucose Tolerance;   Disorder of Glucose Regulation
Interventions: Drug: Metformin XR plus placebo;   Drug: Metformin XR plus liraglutide
9 Recruiting A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ASP4345;   Drug: Matching Placebo
10 Not yet recruiting Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Apalutamide;   Drug: IHT
11 Not yet recruiting Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)
Condition: Hurler Syndrome, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy, Krabbe, Cerebral Adrenoleukodystrophy
Intervention: Drug: Umbilical cord blood transplantation with HSC835
12 Recruiting Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
Conditions: Primary Immune Deficiency Disorders;   Hemophagocytic Lymphohistiocytosis;   Inherited Bone Marrow Failure Syndrome;   Hemoglobinopathies;   Metabolic Disorders
Intervention: Biological: BPX-501 and AP1903
13 Recruiting DAPA, EQW, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Conditions: Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Exenatide once weekly (EQW );   Drug: Dapagliflozin (DAPA);   Drug: EQW plus DAPA;   Drug: Dapagliflozin plus Glucophage (MET ER);   Drug: Phentermine /Topiramate (PHEN/ TRP) ER
14 Recruiting Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Condition: Non-Malignant
Interventions: Procedure: Allogeneic Bone Marrow Transplantation;   Biological: Anti-Thymocyte Globulin;   Drug: Cyclosporine;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Methotrexate;   Drug: Mycophenolate Mofetil;   Procedure: Peripheral Blood Stem Cell Transplantation;   Drug: Tacrolimus;   Radiation: Total-Body Irradiation;   Drug: Treosulfan;   Procedure: Umbilical Cord Blood Transplantation
15 Recruiting Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Conditions: Cushing's Syndrome,;   Ectopic Corticotropin Syndrome,;   Adrenal Adenoma,;   Adrenal Carcinoma,;   AIMAH,;   PPNAD
Intervention: Drug: Osilodrostat
16 Recruiting Treatment for Endogenous Cushing's Syndrome
Condition: Endogenous Cushing's Syndrome
Intervention: Drug: COR-003
17 Recruiting PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
Conditions: Polycystic Ovary Syndrome (PCOS);   Insulin Resistance
Interventions: Drug: DLBS3233;   Drug: Metformin XR;   Drug: Placebo metformin;   Drug: Placebo DLBS3233
18 Recruiting An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
Condition: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
Intervention: Drug: Triheptanoin
19 Recruiting A Long-Term Open-Label Treatment and Extension Study of UX003 rhGUS Enzyme Replacement Therapy in Subjects With MPS 7
Conditions: Sly Syndrome;   MPS VII;   Mucopolysaccharidosis;   Mucopolysaccharidosis VII
Intervention: Drug: UX003
20 Not yet recruiting Pulsed Electromagnetic Field (PEMF) Therapy for Post-Concussive Syndrome
Conditions: Post Concussive Syndrome;   Concussion
Intervention: Device: PEMF

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years